NMN Supplementation in mg

NMN supplementation: dosage, science & longevity context

Nicotinamide mononucleotide (NMN, β-NMN) is a direct precursor to NAD⁺, the coenzyme that drops off as we age. Most research has used doses in the 250–500 mg/day range. Here the calculator scales by body weight: dose_mg = weight_kg × factor_mg_per_kg. At the default 4 mg/kg, a 70 kg adult comes out near 280 mg/day, right inside that most-studied band.

NMN got its moment in the spotlight after David Sinclair’s lab at Harvard Medical School tied NAD⁺ restoration to mitochondrial function, sirtuin activation and biomarkers of biological aging. A couple of regulatory points to keep in mind: in 2022 the U.S. FDA pulled NMN out of the supplement category, citing its status as an investigational drug, and Brazil’s ANVISA has never registered NMN as a food supplement. Long-term human safety data are still thin. Even so, the global NMN market hit roughly US$400 million in 2024.

Applications

People reach for it when exploring NAD⁺ repletion protocols, at longevity clinics, when comparing equivalent doses across body weights, or when a physician needs a sensible starting amount before titrating. Talk to a qualified healthcare provider before you begin. This calculator is educational and doesn't replace medical advice.

FAQ

Is NMN approved by regulators? No. The FDA reclassified it as an investigational drug in 2022, and ANVISA hasn't registered it as a supplement. In several countries it sells in a regulatory gray zone.

What’s the difference between NMN and NR? Both feed into NAD⁺. NR (nicotinamide riboside) is one phosphate group smaller and sells in the U.S. as a registered supplement, Niagen. NMN sits one step closer to NAD⁺ along the salvage pathway.

Are the longevity claims proven? Animal studies (mice) are promising, but robust long-term human RCTs are still scarce. Treat NMN as experimental and consult a clinician.